Cargando…
IgE Antibodies against Cancer: Efficacy and Safety
Immunoglobulin E (IgE) antibodies are well known for their role in allergic diseases and for contributions to antiparasitic immune responses. Properties of this antibody class that mediate powerful effector functions may be redirected for the treatment of solid tumours. This has led to the rise of a...
Autores principales: | Chauhan, Jitesh, McCraw, Alex J., Nakamura, Mano, Osborn, Gabriel, Sow, Heng Sheng, Cox, Vivienne F., Stavraka, Chara, Josephs, Debra H., Spicer, James F., Karagiannis, Sophia N., Bax, Heather J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7709114/ https://www.ncbi.nlm.nih.gov/pubmed/33081206 http://dx.doi.org/10.3390/antib9040055 |
Ejemplares similares
-
Insights from IgE Immune Surveillance in Allergy and Cancer for Anti-Tumour IgE Treatments
por: McCraw, Alex J., et al.
Publicado: (2021) -
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype
por: Nakamura, Mano, et al.
Publicado: (2020) -
AllergoOncology: Expression platform development and functional profiling of an anti‐HER2 IgE antibody
por: Ilieva, Kristina M., et al.
Publicado: (2019) -
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model
por: Williams, Iwan P., et al.
Publicado: (2019) -
Clinical and Translational Significance of Basophils in Patients with Cancer
por: Chauhan, Jitesh, et al.
Publicado: (2022)